ENTOFENTOFOTC
Loading
EBITDA Over TimeExpanding
Percentile Rank79
3Y CAGR+223.2%
5Y CAGR-18.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+223.2%/yr
vs -50.8%/yr prior
5Y CAGR
-18.9%/yr
Recent acceleration
Acceleration
+273.9pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$2.83B+221.1%
2024$883.00M+116.6%
2023$-5.33B-6447.6%
2022$84.00M-98.8%
2021$7.13B-11.7%
2020$8.08B+91.0%
2019$4.23B+196.1%
2018$1.43B+16.7%
2017$1.23B+13.3%
2016$1.08B-